GIPC1 and neoplasm: By optimizing an LGIPCsi for stability, siRNA encapsulation, and selective tumor uptake, the research sought to overcome delivery challenges and assess the therapeutic efficacy of GIPC1 silencing alone or in combination with GEM in orthotopic and patient-derived xenograft models.